(Q37239437)

English

The risks and benefits of therapy with aldosterone receptor antagonist therapy

scientific article published on January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

The risks and benefits of therapy with aldosterone receptor antagonist therapy (English)

1 reference

Europe PubMed Central

19 August 2017

author name string

Domenic A Sica

1

1 reference

Europe PubMed Central

19 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2007

1 reference

Europe PubMed Central

19 August 2017

Current Drug Safety

1 reference

Europe PubMed Central

19 August 2017

2

1 reference

Europe PubMed Central

19 August 2017

1

1 reference

Europe PubMed Central

19 August 2017

71-77

1 reference

Europe PubMed Central

19 August 2017

The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1111/J.1464-5491.2004.01194.X

Identifiers

10.2174/157488607779315499

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37239437&oldid=2098716793"